DiseaseBank™
The deepest repository of target and biomarker IP for complex diseases
Proprietary indication insights
Our scalable platform has generated the deepest disease insights into the biological mechanisms underpinning complex chronic diseasess.
We’ve discovered new biomarkers that identify all clinically relevant patient subgroups who share a disease mechanism, and found novel drug targets and drug repurposing opportunities for treating them.
All of these proprietary and protectable insights are stored in our DiseaseBank repository.
Across therapeutic areas for diseases with unmet medical needs
NeuropsychiatricBipolar
Major depressive disorder
Schizophrenia
NeurologicalALS
Alzheimer's disease
Frontotemporal dementia
Migraine
Multiple sclerosis
Parkinson's disease
MetabolicType-II diabetes complications
Type-I diabetes
NASH/NAFLD
CardiovascularCoronary artery disease
Glaucoma
Atrial Fibrillation
Atherosclerosis
Allergy/InfectiousCOVID-19
Long COVID
Sepsis/ARDS
ME/CFS
RespiratoryAsthma (T2)
Asthma (non-T2)
COPD
Idiopathic pulmonary fibrosis
Women’s HealthEndometriosis
Uterine fibroids
AgingMacular degeneration
Osteoarthritis
GastrointestinalInflammatory bowel disease
Crohn’s disease
Ulcerative colitis
OncologyBreast cancer
Breast cancer CVD risk
Lung cancer
Prostate cancer
DermatologicalAlopecia
Atopic dermatitis
Vitiligo
Auto-immuneRheumatoid arthritis
Sjögren’s syndrome
Cross-disease target discovery
We’ve gathered detailed information on hundreds of key mechanisms and targets, including how they affect major patient subgroups across related conditions.
This has enabled us to identify novel targets and compare their influence and penetrance across multiple diseases.
Precision drug repositioning
DiseaseBank enables INDx, our systematic approach to identifying indication extension opportunities as well as find good tool compounds for early pharmacological target validation in new drug discovery projects.
Patent-ready data packages
DiseaseBank insights form the data packages necessary to support IP filings for a range of purposes.
These include method of use patents linking a drug to a new indication supported by responder biomarkers, patient stratification biomarkers as novel diagnostic tools, drug response biomarkers to enrich clinical trials, and proprietary risk models and clinical decision support tools.
Tab heading
Tab heading
Cross-disease target discovery
We’ve gathered detailed information on hundreds of key mechanisms and targets, including how they affect major patient subgroups across related conditions.
This has enabled us to identify novel targets and compare their influence and penetrance across multiple diseases.
Precision drug repositioning
DiseaseBank enables INDx, our systematic approach to identifying indication extension opportunities as well as find good tool compounds for early pharmacological target validation in new drug discovery projects.
Patent-ready data packages
DiseaseBank insights form the data packages necessary to support IP filings for a range of purposes.
These include method of use patents linking a drug to a new indication supported by responder biomarkers, patient stratification biomarkers as novel diagnostic tools, drug response biomarkers to enrich clinical trials, and proprietary risk models and clinical decision support tools.
Combinatorial analytics
Our unique approach reveals many more of the biological drivers of disease than any other method
Time to insight
Our analysis of chronic diseases rapidly reveals insights that would usually take years of investigation
Deployment platform
We work with collaborators worldwide and protect their most confidential and sensitive data
